Ozempic
Ozempic shortages to continue: Butler
Novo Nordisk “simply doesn’t have the factories” to meet growing demand for Ozempic, Health Minister says Shortages of Novo Nordisk’s diabetes medication, Ozempic (semaglutide) are likely to continue into 2025, …
Caution with click method for semaglutide pen
PDL has become aware of a number of adverse events and health consequences from the popularised method of Ozempic (semaglutide) administration known as “counting clicks” Understanding the click method …
Diabetes shortages targeted in report
Shortages of existing diabetes medicines are likely to continue through 2024 and beyond, warns a new report which recommends strengthening the supply chain The 2024 State of the Nation report from Diabetes …
Ozempic compounding ban no ‘knee-jerk’ reaction
Department defends recommendation to ban the compounding of semaglutide and tirepatide medications Moves to prohibit pharmacists from compounding replicas of Ozempic (semaglutide) and Mounjaro (tirepatide) were not a “knee-jerk response” …
Pharmacy fined over Ozempic advertising
Western Sydney pharmacy hit with a fine of more than $18,000 in relation to alleged unlawful advertising of Ozempic The Therapeutic Goods Administration (TGA) has issued an infringement notice of $18,780 …
Compounding ban ‘a significant public health concern’
Government urged to roll back its ban on compounding weight loss drugs Banning the compounding of glucagon-like peptide-2 receptor agonists (GLP-1RAs) medications will limit patient access to the weight loss …
Government acts on compounding concerns
Compounding exemptions for diabetes medications, Ozempic and Mounjaro, will be removed from 1 October, minister reveals Compounding pharmacies will be barred from producing replicas of Ozempic (semaglutide) and Mounjaro (tirazapetide) …
Severe reactions linked to ‘compounded’ Ozempic
Patient violently ill and vomiting blood after taking illegally compounded Ozempic from an online pharmacy Products being sold as compounded Ozempic (semaglutide) and Mounjaro (tirzepatide) are being linked to severe side …
Will weight loss drugs eat into supermarkets’ profits?
The skyrocketing demand for weight loss medications like Ozempic could temper shoppers’ appetites at our major supermarkets, Morgan Stanley says The Danish maker of GLP-1 receptor antagonists Ozempic and Wegovy, …
Ozempic isn’t approved for weight loss in Australia. So how are people accessing it?
Hundreds of thousands of people worldwide are taking drugs like Ozempic to lose weight. But what do we actually know about them? The Conversation’s experts, Andrew Bartlett, Jessica Pace and …
TGA urges caution over unsolicited compounding offers
GPs are being advised to “exercise deep caution” when contacted with offers to provide compounded semaglutide Prescribers are being warned by the Therapeutic Goods Administration (TGA) not to be “duped” …
Pragmatic approach needed to Ozempic compounding concerns
TGA should crack down on “rogue pharmacists” rather than rolling out a ban on compounding Ozempic (semaglutide), an obesity expert claims Pragmatism is needed when it comes to regulating the …